期刊文献+

Cryoablation combined with radiotherapy for hepatic malignancy:Five case reports 被引量:2

Cryoablation combined with radiotherapy for hepatic malignancy:Five case reports
下载PDF
导出
摘要 BACKGROUND The survival of patients treated with monotherapy for hepatic malignancies is not ideal.A comprehensive program of cryoablation combined with radiotherapy for the treatment of hepatic malignancies results in less trauma to the patients.It may provide an option for the treatment of patients with advanced hepatic malignancies.CASE SUMMARY We reported 5 cases of advanced-stage hepatic malignancies treated in our hospital from 2017-2018,including 3 cases of primary hepatocellular carcinoma and 2 cases of metastatic hepatic carcinoma.They first received cryoablation therapy on their liver lesions.The procedure consisted of 2 freeze-thaw cycles,and for each session,the duration of freezing was 13-15 min,and the natural rewarming period was 2-8 min.Depending on the tumor size,the appropriate cryoprobes were selected to achieve complete tumor ablation to the greatest extent possible.After cryoablation surgery,intensity-modulated radiotherapy(IMRT)for liver lesions was performed,and the radiotherapy regimen was 5400 cGy/18f and 300 cGy/f.None of the 5 patients had adverse events above grade II,and their quality of life was significantly improved.Among them,4 patients were free of disease progression in the liver lesions under local control,and their survival was prolonged;3 patients are still alive.CONCLUSION Our clinical practice demonstrated that cryoablation combined with IMRT could be implemented safely.The definitive efficacy for hepatic malignancies needs to be confirmed in larger-size sample prospective studies. BACKGROUND The survival of patients treated with monotherapy for hepatic malignancies is not ideal. A comprehensive program of cryoablation combined with radiotherapy for the treatment of hepatic malignancies results in less trauma to the patients. It may provide an option for the treatment of patients with advanced hepatic malignancies.CASE SUMMARY We reported 5 cases of advanced-stage hepatic malignancies treated in our hospital from 2017-2018, including 3 cases of primary hepatocellular carcinoma and 2 cases of metastatic hepatic carcinoma. They first received cryoablation therapy on their liver lesions. The procedure consisted of 2 freeze-thaw cycles,and for each session, the duration of freezing was 13-15 min, and the natural rewarming period was 2-8 min. Depending on the tumor size, the appropriate cryoprobes were selected to achieve complete tumor ablation to the greatest extent possible. After cryoablation surgery, intensity-modulated radiotherapy(IMRT) for liver lesions was performed, and the radiotherapy regimen was 5400 c Gy/18 f and 300 c Gy/f. None of the 5 patients had adverse events above grade II, and their quality of life was significantly improved. Among them, 4 patients were free of disease progression in the liver lesions under local control, and their survival was prolonged; 3 patients are still alive.CONCLUSION Our clinical practice demonstrated that cryoablation combined with IMRT could be implemented safely. The definitive efficacy for hepatic malignancies needs to be confirmed in larger-size sample prospective studies.
出处 《World Journal of Gastrointestinal Oncology》 SCIE CAS 2020年第2期237-247,共11页 世界胃肠肿瘤学杂志(英文版)(电子版)
基金 Supported by Health Commission of Hebei Province,No.G2018068
关键词 Hepatic malignancies Primary hepatocellular carcinoma Metastatic hepatic carcinoma CRYOABLATION Intensity-modulated radiotherapy Case report Hepatic malignancies Primary hepatocellular carcinoma Metastatic hepatic carcinoma Cryoablation Intensity-modulated radiotherapy Case report
  • 相关文献

参考文献2

二级参考文献27

  • 1Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量:214
  • 2[4]Gournay J, Tchuenbou J, Richou C, Masliah C, Lerat F, Dupas B, Martin T, Nouel JF, Schnee M, Montigny P, D'Alincourt A, Hamy A, Paineau J, Le Neel JC, Le Borgne J, Galmiche JP.Percutaneous ethanol injection vs. resection in patients with small single hepatocellular carcinoma: a retrospective casecontrol study with cost analysis. Aliment Pharmacol Ther 2002;16:1529-1538
  • 3[5]Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N,Hasegawa H, Nakajima Y, Ohnishi K. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56:918-928
  • 4[6]Groupe d'Etude et de Traitement du Carcimome Hepatocelltaire.A comparison of lipiodol, chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995; 332:1256-1261
  • 5[7]Lau WY, Leung TW, Yu SC, Ho SK. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg 2003; 237:171-179
  • 6[8]Crews KA, Kuhn JA, McCarty TM, Fisher TL, Goldstein RM,Preskitt JT. Cryosurgical ablation of hepatic tumors. Am J Surg 1997; 174:614-618
  • 7[9]Lam CM, Yuen WK, Fan ST. Hepatic cryoablation for recurrent hepatocellular carcinoma after hepatectomy:a preliminary report.Xu KC et al. Cryoablation for hepatocellular carcinoma J Surg Oncol 1998; 68:104-106
  • 8[10]Sheen AJ, Poston GJ, Sherlock DJ. Cryotherapeutic ablation of liver tumours. Br J Surg 2002; 89:1396-1401
  • 9[11]Zhou XD, Tang ZY, Yu YQ, Ma ZC. Clinical evaluation of cryosurgery in the treatment of primary liver cancer. Report of 60 cases. Cancer 1988; 61:1889-1892
  • 10[12]Zhou XD, Tang ZY, Yu YQ, Weng JW, Ma ZC, Zhang BH, Zheng YX. The role of cryosurgery in the treatment of hepatic cancer:areport of 113 cases. J Cancer Res Clin Oncol 1993; 120:100-102

共引文献45

同被引文献8

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部